Highlights of the 5th edition of HTID®, organized by HealthTech For Care

02 November 2023 - Assobiotec was a partner of the HealthTech Innovation Days (HTID®) that brought together 750 participants on October 24 and 25, and remotely on October 27, including researchers, public players, industry leaders, patients’ associations, patients, investors and entrepreneurs in Paris.

The 5th edition of the HealthTech Innovation Days (HTID®), organized by HealthTech For Care (HTFC), brought together key players in European healthcare innovation over a period of 2 days, to accelerate the development and market access of new products and treatments for patients.

Some 2.000 in-person and virtual meetings took place this year, reflecting growing interest in the event. The event brought together 174 European health technology companies, 15 pharmaceutical and industrial companies and over 250 international investors, featuring 60 international experts, who conducted 13 roundtable discussions, and 3 keynotes.

For the 5th consecutive year, HTID® benefited from the High Patronage of Emmanuel Macron, President of France, and support from the French public sector, with the participation of Olivier Becht, Deputy to the Minister of Europe and Foreign Affairs. The event was also supported by representatives from European institutions, including Dana Burduja and Cristina Niculescu from the European Investment Bank, Olga Solomon, Acting Director DPT, Medical Products and Innovation, DG Santé-European commission, Olivier Gérard, Head of Unit, Medical Counter-Measures, European Commission, Iordanis Arzimanoglou, Enric Claverol-Tinturé from the European Innovation Council and Alain Godard, Chairman and Managing Director, European Fund for Digital Sovereignty, the "European Tech Champions Initiative".

In addition, HTFC co-organized an HTID® launch event at The Ministery of Economy and Finance at Bercy, including Roland Lescure, Deputy Minister for Industry, and Olivier Becht. The event brought together some hundred French and foreign players in healthcare innovation, including HTFC’s sponsors, focusing in particular on two key aspects of healthcare innovation: talent and financing.

"For the past five years, HTID® has proven its value for the European healthcare ecosystem, enabling companies to bring innovations to market for the benefit of patients. Europe has a real need to work together to become a truly global force in healthcare, and HTID® has succeeded in establishing itself as Europe's benchmark event for European healthcare. We would once again like to thank our sponsors, our collaborators and our Board, without whom this event could not have taken place", said
Maryvonne Hiance, President of HTFC, the organizer of HTID®.

HealthTech For Care Innovation Award: The HealthTech For Care Innovation Award, presented for the second time at HTID®, offered 22 HealthTech companies from 8 countries the opportunity to present their solutions to healthcare experts and investors in a pitch competition.

Among the winners of this second edition there is an Italian biotech company, Yore:
- 1st Prize: Neuroclues
- 2nd Prize: Previa Medical
- 3rd Prize: Yore.

The winner was awarded the HealthTech For Care Innovation prize, allowing them to establish privileged connections with the H’FC's sponsors, gain visibility through dedicated communication, and free access to the 6th edition of HTID®.

HealthTech For Care is supported by its founder France Biotech and by Assobiotec and other associations like Asebio, Atlanpole Biotherapies, BIA Association, BioAlps, Biocentury, BIO Deutschland, BioRegioStern, BioValley France, BioWin, CEBR,
clubster NSL, Danish LifeScience Cluster, EuroBioMed, French Healthcare, flanders.bio, LyonBioPole, Medicen, Medtech Europe, Medvia, Swiss Biotech and Technion France.

For more information: https://htfc-eu.com/htid/

Where to find us

20149 Milan
Via Giovanni da Procida, 11
Show map 
Tel. +39 02.34565.1
Fax. +39 02.34565.310
Segreteria Assobiotec
Tel. 02 34565.256/341